Total: 2198

    Stroke and transient ischaemic attack in over 16s: diagnosis and initial management

    This guideline covers interventions in the acute stage of a stroke or transient ischaemic attack (TIA). It offers the best clinical advice on the diagnosis and acute management of stroke and TIA in the 48 hours after onset of symptoms. In April 2022, we reviewed the evidence and made new recommendations...

    Management of Postmenopausal Osteoporosis: ACOG Clinical Practice Guideline No. 2

    Obstet. gynecol; 139 (4), 2022
    To provide updated evidence-based recommendations for the treatment of postmenopausal osteoporosis. This guideline was developed using an a priori protocol in conjunction with a writing team consisting of two specialists in obstetrics and gynecology appointed by the ACOG Committee on Clinical Practice Gu...

    Neurogenic bladder: concepts and treatment recommendations

    Int. braz. j. urol; 48 (2), 2022
    Bladder and urinary sphincter malfunctioning that results from some change in the central and/or peripheral nervous system is defined as neurogenic bladder. The urinary tract symptoms that can be related to its filling, emptying, or both have a significant impact on the quality of life of individuals. Th...

    Doporučené postupy pro diagnostiku a léčbu Parkinsonovy nemoci

    Parkinson's disease (PN) is a chronic, incurable, disabling disease; it is the most common degenerative disease of the nervous system. PN is characterized by a set of clinical manifestations that include slowness of movement (bradykinesia), resting tremor, rigidity, and postural instability. PN is a comp...

    Maternal and fetal assessment update: imaging ultrasound before 24 weeks of pregnancy

    This recommendation is an update of one of the 49 recommendations that were published in the WHO recommendations on antenatal care for a positive pregnancy experience. The recommendation was developed initially using the standardized operating procedures described in the WHO handbook for guideline develo...

    Guideline for the diagnosis and treatment of faecal incontinence: a UEG/ESCP/ESNM/ESPCG collaboration [Pré-print]

    The goal of this project was to create an up-to-date joint European clinical practice guideline for the diagnosis and treatment of faecal incontinence (FI), using the best available evidence. These guidelines are intended to help guide all medical professionals treating adult patients with FI (e.g., gene...

    CDC clinical practice guideline for prescribing opioids for pain: United States, 2022

    MMWR recomm. rep; 71 (3), 2022
    This guideline provides recommendations for clinicians providing pain care, including those prescribing opioids, for outpatients aged ≥18 years. It updates the CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016 (MMWR Recomm Rep 2016;65[No. RR-1]:1–49) and includes recommen...

    Hypertension in adults: diagnosis and management

    This guideline covers identifying and treating primary hypertension (high blood pressure) in people aged 18 and over, including people with type 2 diabetes. It aims to reduce the risk of cardiovascular problems such as heart attacks and strokes by helping healthcare professionals to diagnose hypertension...

    The role of preoperative optimization of the nutritional status on the improvement of short-term outcomes after liver transplantation? A review of the literature and expert panel recommendations [Pré-print]

    Malnutrition is a known risk factor for postoperative morbidity and mortality in patients awaiting liver transplantation (LT). Malnutrition is a potentially reversible risk factor, though there are no clear guidelines on the best mechanism for an improvement. It also remains unclear if preoperative nutri...

    Use of the Janssen (Johnson & Johnson) COVID-19 vaccine: updated interim recommendations from the advisory committee on immunization practices: United States, December 2021

    MMWR recomm. rep; 71 (3), 2022
    On February 27, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the adenovirus-vectored COVID-19 vaccine (Janssen Biotech, Inc., a Janssen Pharmaceutical company, Johnson & Johnson), and on February 28, 2021, the Advisory Committee on Immunization Practices (A...